Abstract

PurposeThis study was designed to evaluate the predictive performance of contrast-enhanced CT-based radiomic features for the personalized, differential diagnosis of esophagogastric junction (EGJ) adenocarcinoma at stages T3 and T4a.MethodsTwo hundred patients with T3 (n = 44) and T4a (n = 156) EGJ adenocarcinoma lesions were enrolled in this study. Traditional computed tomography (CT) features were obtained from contrast-enhanced CT images, and the traditional model was constructed using a multivariate logistic regression analysis. A radiomic model was established based on radiomic features from venous CT images, and the radiomic score (Radscore) of each patient was calculated. A combined nomogram diagnostic model was constructed based on Radscores and traditional features. The diagnostic performances of these three models (traditional model, radiomic model, and nomogram) were assessed with receiver operating characteristics curves. Sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and areas under the curve (AUC) of models were calculated, and the performances of the models were evaluated and compared. Finally, the clinical effectiveness of the three models was evaluated by conducting a decision curve analysis (DCA).ResultsAn eleven-feature combined radiomic signature and two traditional CT features were constructed as the radiomic and traditional feature models, respectively. The Radscore was significantly different between patients with stage T3 and T4a EGJ adenocarcinoma. The combined nomogram performed the best and has potential clinical usefulness.ConclusionsThe developed combined nomogram might be useful in differentiating T3 and T4a stages of EGJ adenocarcinoma and may facilitate the decision-making process for the treatment of T3 and T4a EGJ adenocarcinoma.

Highlights

  • In 1996, Siewert et al defined esophagogastric junction (EGJ) adenocarcinoma as tumors with a center located within 5 cm proximal and distal to the anatomical cardia [1]

  • The main objective of this study was to evaluate the predictive performance of contrast-enhanced CT-based radiomic features for the personalized, differential diagnosis of T3 and T4a EGJ adenocarcinoma

  • This study further explored whether the combination of radiomic and traditional features would further improve the accuracy of model performance

Read more

Summary

Introduction

In 1996, Siewert et al defined esophagogastric junction (EGJ) adenocarcinoma as tumors with a center located within 5 cm proximal and distal to the anatomical cardia [1]. A study conducted in China showed that the incidence of EGJ adenocarcinoma increased from 22.3 to 35.7% from 1988 to 2012 [3]. According to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual 8th edition, the anatomical boundary of EGJ tumors was defined as follows: “tumors involving the EGJ with the tumor epicenter no more than 2 cm into the proximal stomach are staged as esophageal cancers; EGJ tumors with their epicenter located greater than 2 cm into the proximal stomach are staged as stomach cancers” [5]. Siewert type III EGJ adenocarcinoma uses gastric cancer staging, while type I and type II EGJ adenocarcinoma still uses esophageal cancer staging [6]

Objectives
Methods
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.